Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

1001-OR: Targeted Deletion of Sphingosine 1-Phosphate Receptor 1 (S1PR1) in T Cells Confers Renoprotection in Diabetic Mice

View through CrossRef
Introduction and Objective: Diabetic kidney disease (DKD) arises from complex metabolic, hemodynamic, and inflammatory mechanisms. Sphingosine-1-phosphate receptor 1 (S1PR1) signaling regulates T-lymphocyte trafficking and immune activation; however, its role in DKD progression remains incompletely defined. This study investigated whether T-cell-specific S1PR1 signaling contributes to DKD development. Methods: Diabetes was induced in mice with T-cell-specific deletion of S1PR1 (S1PR1−/−) and wild-type littermates (S1PR1+/+) using daily streptozotocin injections (50 mg/kg) for 3-5 days. Metabolic parameters and albumin excretion rate (AER) were assessed over 15 weeks. Renal injury was evaluated by mesangial expansion, CD4+ T-cell infiltration, and inflammatory gene expression using PAS staining, flow cytometry, and PCR analyses. Results: Plasma glucose levels were similarly elevated in diabetic S1PR1+/+ and S1PR1−/− mice compared with controls. Despite comparable hyperglycemia, diabetic S1PR1−/− mice exhibited a significant reduction in AER (46%, p<0.034) and attenuated mesangial expansion relative to diabetic S1PR1+/+ mice. Diabetes markedly increased renal CD4+ T-cell infiltration in S1PR1+/+ mice (28.6%), which was significantly reduced in S1PR1−/− mice (17%, p<0.0002). T-cell-specific S1PR1 deletion was also associated with decreased renal expression of inflammatory and injury markers, including TGF-β, TNF-α, and NGAL. Conclusion: Targeted deletion of S1PR1 in T cells confers significant renoprotection in diabetic mice by reducing albuminuria, preserving renal structure, and limiting inflammatory responses. These findings identify T-cell S1PR1 signaling as a novel immunomodulatory contributor to DKD progression and a potential therapeutic target. Disclosure M. Itani: None. K.H. SharafAlDeen: None. M.A. Jaffa: None. F.N. Ziyadeh: None. H. Itani: None. A. Jaffa: None. Funding Medical Practice Plan/ University Research Board- AUB
Title: 1001-OR: Targeted Deletion of Sphingosine 1-Phosphate Receptor 1 (S1PR1) in T Cells Confers Renoprotection in Diabetic Mice
Description:
Introduction and Objective: Diabetic kidney disease (DKD) arises from complex metabolic, hemodynamic, and inflammatory mechanisms.
Sphingosine-1-phosphate receptor 1 (S1PR1) signaling regulates T-lymphocyte trafficking and immune activation; however, its role in DKD progression remains incompletely defined.
This study investigated whether T-cell-specific S1PR1 signaling contributes to DKD development.
Methods: Diabetes was induced in mice with T-cell-specific deletion of S1PR1 (S1PR1−/−) and wild-type littermates (S1PR1+/+) using daily streptozotocin injections (50 mg/kg) for 3-5 days.
Metabolic parameters and albumin excretion rate (AER) were assessed over 15 weeks.
Renal injury was evaluated by mesangial expansion, CD4+ T-cell infiltration, and inflammatory gene expression using PAS staining, flow cytometry, and PCR analyses.
Results: Plasma glucose levels were similarly elevated in diabetic S1PR1+/+ and S1PR1−/− mice compared with controls.
Despite comparable hyperglycemia, diabetic S1PR1−/− mice exhibited a significant reduction in AER (46%, p<0.
034) and attenuated mesangial expansion relative to diabetic S1PR1+/+ mice.
Diabetes markedly increased renal CD4+ T-cell infiltration in S1PR1+/+ mice (28.
6%), which was significantly reduced in S1PR1−/− mice (17%, p<0.
0002).
T-cell-specific S1PR1 deletion was also associated with decreased renal expression of inflammatory and injury markers, including TGF-β, TNF-α, and NGAL.
Conclusion: Targeted deletion of S1PR1 in T cells confers significant renoprotection in diabetic mice by reducing albuminuria, preserving renal structure, and limiting inflammatory responses.
These findings identify T-cell S1PR1 signaling as a novel immunomodulatory contributor to DKD progression and a potential therapeutic target.
Disclosure M.
Itani: None.
K.
H.
SharafAlDeen: None.
M.
A.
Jaffa: None.
F.
N.
Ziyadeh: None.
H.
Itani: None.
A.
Jaffa: None.
Funding Medical Practice Plan/ University Research Board- AUB.

Related Results

Intervening in the S1PR1/STAT3 Signaling Pathway Attenuates Valvular Damage Due to Rheumatic Heart Disease
Intervening in the S1PR1/STAT3 Signaling Pathway Attenuates Valvular Damage Due to Rheumatic Heart Disease
Abstract Background: Rheumatic heart disease (RHD) affects many patients every year, but its pathogenesis is still unclear. Recent studies have found that the sphingosine 1...
Sphingosine 1-phosphate signaling in platelet production
Sphingosine 1-phosphate signaling in platelet production
Signalisation de la Sphingosine 1-phosphate dans la production de plaquettes La Sphingosine 1-phosphate (S1P) est un médiateur bioactif produit lors de la phosphory...
Sphingosine Prevents Rhinoviral Infections
Sphingosine Prevents Rhinoviral Infections
Rhinoviral infections cause approximately 50% of upper respiratory tract infections and novel treatment options are urgently required. We tested the effects of 10 μM to 20 μM sphin...
Renal tubular (pro)renin receptor deletion does not protect against kidney injury in db/db mice
Renal tubular (pro)renin receptor deletion does not protect against kidney injury in db/db mice
Background: The (pro)renin receptor (PRR) is a multifunctional protein implicated in blood pressure regulation and kidney fibrosis. Previous studies report enhanced PRR expression ...
Sphingosine 1-phosphate signalling in mammalian cells
Sphingosine 1-phosphate signalling in mammalian cells
Sphingosine 1-phosphate is formed in cells in response to diverse stimuli, including growth factors, cytokines, G-protein-coupled receptor agonists, antigen, etc. Its production is...
Inhaled Sphingosine Has no Adverse Side Effects in Isolated Ventilated and Perfused Pig Lungs
Inhaled Sphingosine Has no Adverse Side Effects in Isolated Ventilated and Perfused Pig Lungs
Abstract Background: Ex-vivo lung perfusion (EVLP) systems like XVIVOâ are more and more common in the setting of lung transplantation, since marginal donor-lungs can easil...
Supplementary Data from Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors
Supplementary Data from Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors
<p>Supplementary Methods, Supplementary Figures S1-S15 Fig. S1. Purification and binding specificity of MV-encoded BiTEs. (A) Purification of MV-expressed BiTEs. Vero cells w...

Back to Top